Abstract: The present invention provides a method and device for visualizing and treating an injury, wound or skin, using a visual tourniquet and skin bandage system made of transparent materials. The inventive bandage system is capable of applying pressure while absorbing bodily fluids away from the wound or skin and providing support for the application of one or more medicaments or a combination of treatment gas and/or medicine. The inventive bandage system enables the practitioner to visually inspect and measure the size of the wound over time without removing or touching the bandage or tourniquet thereby reducing pain and contamination of the wound bed. One embodiment of the inventive bandage system continuously controls the wound bed temperature thereby reducing pain and inhibiting bacterial growth. Other embodiments of the inventive bandage system are used as a visual tourniquet to apply a combination of pressures to a wound or skin injury.

Abstract: A process and assay for determining the neurological condition in a subject is provided whereby the level of one or more neuroactive biomarkers is measured in a sample obtained from the subject. The processes and assay include measurement of multiple neuroactive biomarkers for synergistic determination of a neurological condition such as neurological damage due to injury, disease, contact with a compound, or other source.

Abstract: A process and assay for determining the neurological condition in a subject is provided whereby the level of one or more neuroactive biomarkers is measured in a sample obtained from the subject. The processes and assay include measurement of multiple neuroactive biomarkers for synergistic determination of a neurological condition such as neurological damage due to injury, disease, contact with a compound, or other source.

Abstract: A process is provided of delivering at least one active agent cargo molecule into an neuronal cell whereby a cargo molecule is placed within a synthetic vesicle such as a liposome and a biotinylated protein such as an antibody is bound to the synthetic vesicle to form a protein bound synthetic vesicle whereby the protein recognizes a receptor expressed on the surface of a neuronal cell, and exposing the protein bound synthetic vesicle to the cell until the cargo molecule is delivered into the neuronal cell. Numerous cargo molecules are delivered by the inventive synthetic vesicle including a calpain inhibitor and a caspase inhibitor. The protein illustratively targets a cellular receptor for a ligand such as glutamate, glycine, dopamine, nicotine, muscarine, acetylcholine, or serotonin, and the like.